In summary, we found that elevated circulating plasma proteins CXCL13, ADA, CXCL9, MUC16, and CCL17 as well as NY-ESO-1 autoantibodies were associated with poor outcomes to treatment with BV combined with I, N, or both. The gene discussed is CCL17; the disease is bacterial vaginosis.